Al Saadi et al (2019): Pharmacomodulation using palladium catalyze November 2019 Vol. 22(7) Pharmacomodulation of positions two & four of nucleus five-nitroimidazole by using palladium catalyze Noor Thamer Abbas Al Saadi 1* Marwah Thamer Abbas Al Saadi1, Zina Tahsin Ali1 1. College of pharmacy, Almuthanna University *Corresponding Author: Dr. Noor Thamer Abbas Al Saadi, College of pharmacy, Almuthanna University Email:
[email protected] Abstract: Cross-coupling reactions consist of reactions between an electrophilic organic species such as a halide or a pseudohalide (triflate, tosylate, mesylate) (R1-X) and an organometallic reagent (R2-M; M = Mg, Li, Cu, Zn, Al, B and Si). These reactions are catalyzed by a metal transition complex based on nickel or palladium, and result in the formation of new CClO.sub.2 bonds. Many cross-coupling reactions have thus been developed in about twenty years, by varying the nature of the electrophile, organometallic reagent and transition metal (Scheme 1). The most commonly used coupling reactions involve palladium as a transition metal, and the diversity of these reactions is based on the type of organometallic used, based on aluminum, zinc or zirconium (Negishi coupling), [1] boron (Suzuki coupling), [2] magnesium (Kumada coupling), [3] tin (Stille coupling) , [4] or silicon (coupling of Hiyama) .[5] The development of this type of reaction allowed Richard Heck, Ei-ichi Negishi and Akira Suzuki to be awarded the Nobel Prize for Chemistry in 2010.[1]. Key words: Pharmacomodulation, nitromidazole, palladiumcatalyz, cross-coupling, reactions How to cite this article: Al Saadi NTA, Al Saadi MTA, Ali ZT (2019): Pharmacomodulation of positions two & four of nucleus five-nitroimidazole by using palladiumcatalyz, Ann Trop Med Pub Health; 22: S202.